Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Advisory Committees

Bibliography FDA Briefing Document; Cell Lines Derived from Human Tumors for Vaccine Manufacture

Vaccines and Related Biological Products Advisory Committee Meeting
September 19, 2012

FDA Guidance for Industry; Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, February 2010

Thomas P. Niedringhaus, Denitsa Milanova, Matthew B. Kerby, Michael P. Snyder, Annelise E. Barron. 2011. Landscape of Next-Generation Sequencing Technologies, Review. Analytical Chemistry 83: 4327-4341

Page Last Updated: 10/13/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English